AurimMed Pharma is a product-oriented, market-driven, and applied-science development-stage pharmaceutical company. AurimMed is developing small-molecule pharmaceutical products by using carefully selected privileged structures as lead compounds for proprietary product development. This rational, proven strategy greatly shortens product development times while enhancing clinical and commercial success. The company is currently developing compounds active in the Central Nervous System (CNS) such as novel anticonvulsants, analgesics (for neuropathic pain), and neuroprotective agents. Such CNS-active agents are also often useful in the treatment of anxiety, depression, insomnia, schizophrenia, Parkinson’s disease, and bipolar disorder. The initial focus of AurimMed Pharma is the development of safe and effective drug products up through Phase I clinical trials. Upon completion of the initial trials, the Company intends to seek agreements with larger biopharmaceutical and/or large pharmaceutical companies in order to co-develop the products through Phase II/III clinical trials. Alternatively, the company would consider licensing the products to companies with existing marketing and business development infrastructure for the marketing of drug products.
View Top Employees from AurimMed Pharma Inc.Website | http://www.aurimmed.com |
Revenue | $1 million |
Employees | 1 (1 on RocketReach) |
Founded | 2007 |
Address | P.O. Box 980007, Park City, Utah 84098, US |
Phone | (435) 513-0967 |
Technologies |
HTML,
G Suite,
ASP.NET
+2 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Anticonvulsant Agents, Retail, Analgesics, SMA, Neuroprotection |
Web Rank | 27 Million |
Competitors | Arrien Pharmaceuticals, Astraea Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Levolta Pharmaceuticals, Inc., P2D Bioscience |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular AurimMed Pharma Inc. employee's phone or email?
The AurimMed Pharma Inc. annual revenue was $1 million in 2024.
Michael Cederstrom is the Executive Vice President of Legal Affairs of AurimMed Pharma Inc..
1 people are employed at AurimMed Pharma Inc..
AurimMed Pharma Inc. is based in Park City, Utah.
The NAICS codes for AurimMed Pharma Inc. are [3254, 325, 32, 32541].
The SIC codes for AurimMed Pharma Inc. are [28, 283].